Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mediator complex subunit 15 pseudogene 3 (MED15P3) is classified as a **pseudogene**, meaning it is a genomic DNA sequence similar to a known gene (in this case, MED15) but generally considered non-functional and does not encode a functional protein[1][3][5][7]. Pseudogenes, including MED15P3, typically arise from duplication or retrotransposition events and may lose protein-coding ability due to mutations, deletions, or insertions[5]. While most pseudogenes do not produce functional proteins and are not drug targets, they can play regulatory roles at the RNA level—for example, by competing for microRNAs or affecting mRNA stability of their parental genes[5]. MED15P3 is related to the parental gene MED15, which encodes a subunit of the mediator complex involved in RNA polymerase II transcription, but there is no evidence that MED15P3 serves as a therapeutic target or is directly involved in any disease mechanisms[1][3][7]. There is also no evidence for any drug interaction, biomarker role, or notable safety concerns for MED15P3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mediator complex subunit 15 pseudogene 3 (MED15P3).